Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01750073
Title Paclitaxel and Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Patients With Previously Untreated Stage I-III Breast Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Nebraska
Indications

breast cancer

Therapies

Doxorubicin

Trastuzumab

Cyclophosphamide + Paclitaxel

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Nebraska Medicine-Bellevue Bellevue Nebraska 68123 United States Details
CHI Health Saint Francis Grand Island Nebraska 68803 United States Details
Nebraska Medicine-Village Pointe Cancer Center Omaha Nebraska 68118 United States Details
University of Nebraska Medical Center Omaha Nebraska 68198 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field